Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance

Cambodia's first-line artemisinin combination therapy, dihydroartemisinin-piperaquine (DHA-PPQ), is no longer sufficiently curative against multidrug-resistant Plasmodium falciparum malaria at some Thai-Cambodian border regions. We report recent (2008 to 2013) drug resistance trends in 753 isol...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Chaorattanakawee, Suwanna, Saunders, David L., Sea, Darapiseth, Chanarat, Nitima, Yingyuen, Kritsanai, Sundrakes, Siratchana, Saingam, Piyaporn, Buathong, Nillawan, Sriwichai, Sabaithip, Chann, Soklyda, Se, Youry, Yom, You, Heng, Thay Kheng, Kong, Nareth, Kuntawunginn, Worachet, Tangthongchaiwiriya, Kuntida, Jacob, Christopher, Takala-Harrison, Shannon, Plowe, Christopher, Lin, Jessica T., Chuor, Char Meng, Prom, Satharath, Tyner, Stuart D., Gosi, Panita, Teja-Isavadharm, Paktiya, Lon, Chanthap, Lanteri, Charlotte A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2015
Soggetti:
Epidemiology and Surveillance
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505231/
https://ncbi.nlm.nih.gov/pubmed/26014942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00366-15
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi